Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, . . . Kulkanya Chokephaibulkit. (2022). Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSuvimol Niyomnaitham, et al. Immunogenicity and Reactogenicity Against the SARS-CoV-2 Variants Following Heterologous Primary Series Involving CoronaVac, ChAdox1 NCov-19 and BNT162b2 Plus BNT162b2 Booster Vaccination: An Open-label Randomized Study in Healthy Thai Adults. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationSuvimol Niyomnaitham, et al. Immunogenicity and Reactogenicity Against the SARS-CoV-2 Variants Following Heterologous Primary Series Involving CoronaVac, ChAdox1 NCov-19 and BNT162b2 Plus BNT162b2 Booster Vaccination: An Open-label Randomized Study in Healthy Thai Adults. Taylor & Francis Group, 2022.